Hepatobiliary disease associated with COVID-19
DOI:
https://doi.org/10.52784/27112330.155Keywords:
COVID-19, SARS-CoV-2, liver, liver diseases, vaccines.Abstract
COVID-19, caused by the type 2 coronavirus (SARS-CoV-2), has had a major impact on health worldwide. Despite being mainly a respiratory disease, the SARS-CoV-2 virus is also responsible for other types of extrapulmonary manifestations, such as hepatobiliary diseases. This review describes the possible mechanisms of pathogenesis involved in liver injury caused by SARS-CoV-2, the relationship between COVID-19 and chronic liver disease, the effects that it has on hepatocellular carcinoma and liver transplantation, as well as the recommendations for vaccination against SARS-CoV-2 in patients affected by liver disease. Finally, some strategies are suggested to overcome the challenge faced by the clinician in the management of patients with hepatobiliary disease and COVID-19.
Downloads
References
Chen AT, Wang CY, Zhu WL, Chen W. Coagulation disorders and thrombosis in COVID-19 patients and a possible mechanism involving endothelial cells: A review. Aging Dis 2022;13:144-156. https://doi.org/10.14336/ad.2021.0704.
Al-Saadi E, Abdulnabi MA. Hematological changes associated with COVID-19 infection. J Clin Lab Anal 2022;36:e24064. https://doi.org/10.1002/jcla.24064.
Forero-Saldarriaga S, Puerta-Rojas JD, Estupiñán-Paredes RN, Coy-Pedraza LC, Moreno-Ruiz NL, Castellanos-Parada J. Infección por SARS-CoV-2 y miocarditis. Med Lab 2022;26:35-46. https://doi.org/10.36384/01232576.558.
The Task Force for the management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-Epidemiology, pathophysiology, and diagnosis. European Heart Journal 2021;43:1033-1058. https://doi.org/10.1093/eurheartj/ehab696.
Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J 2022;43:1059-1103. https://doi.org/10.1093/eurheartj/ehab697.
Chen F, Dai Z, Huang C, Chen H, Wang X, Li X. Gastrointestinal disease and COVID-19: A review of current evidence. Dig Dis 2021:1-9. https://doi.org/10.1159/000519412.
Hunt RH, East JE, Lanas A, Malfertheiner P, Satsangi J, Scarpignato C, et al. COVID-19 and gastrointestinal disease: Implications for the gastroenterologist. Dig Dis 2021;39:119-139. https://doi.org/10.1159/000512152.
Ozkurt Z, Çınar-Tanrıverdi E. COVID-19: Gastrointestinal manifestations, liver injury and recommendations. World J Clin Cases 2022;10:1140-1163. https://doi.org/10.12998/wjcc.v10.i4.1140.
Singh J, Malik P, Patel N, Pothuru S, Israni A, Chakinala RC, et al. Kidney disease and COVID-19 disease severity-systematic review and meta-analysis. Clin Exp Med 2022;22:125-135. https://doi.org/10.1007/s10238-021-00715-x.
Jdiaa SS, Mansour R, El Alayli A, Gautam A, Thomas P, Mustafa RA. COVID-19 and chronic kidney disease: an updated overview of reviews. J Nephrol 2022;35:69-85. https://doi.org/10.1007/s40620-021-01206-8.
Hingorani KS, Bhadola S, Cervantes-Arslanian AM. COVID-19 and the brain. Trends Cardiovasc Med 2022. https://doi.org/10.1016/j.tcm.2022.04.004.
Sarubbo F, El Haji K, Vidal-Balle A, Bargay Lleonart J. Neurological consequences of COVID-19 and brain related pathogenic mechanisms: A new challenge for neuroscience. Brain Behav Immun Health 2022;19:100399. https://doi.org/10.1016/j.bbih.2021.100399.
Maiese A, Manetti AC, Bosetti C, Del Duca F, La Russa R, Frati P, et al. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Brain Pathol 2021;31:e13013. https://doi.org/10.1111/bpa.13013.
García-Rueda JE, Caicedo-Bolaños AM, Bermúdez-Flórez AM, Baena-Gallego F, Gómez-Ramírez LA, Correa-Ángel AL, et al. Pitiriasis rosada como manifestación dermatológica de infección por SARS-CoV-2: a propósito de un caso. Med Lab 2022;26:177-186. https://doi.org/10.36384/01232576.575.
Polly S, Fernandez AP. Common skin signs of COVID-19 in adults: An update. Cleve Clin J Med 2022;89:161-167. https://doi.org/10.3949/ccjm.89a.21126.
Seque CA, Enokihara M, Porro AM, Tomimori J. Skin manifestations associated with COVID-19. An Bras Dermatol 2022;97:75-88. https://doi.org/10.1016/j.abd.2021.08.002.
Akl J, El-Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol 2021;20:3105-3115. https://doi.org/10.1111/jocd.14266.
Rao A, Puertolas M, Runde J. COVID-19 and gastrointestinal and hepatobiliary diseases. Pediatr Ann 2021;50:e315-e319. https://doi.org/10.3928/19382359-20210721-02.
Patel KP, Patel PA, Vunnam RR, Hewlett AT, Jain R, Jing R, et al. Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19. J Clin Virol 2020;128:104386. https://doi.org/10.1016/j.jcv.2020.104386.
Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and indirect liver injury: A narrative synthesis of the evidence. J Clin Transl Hepatol 2021;9:760-768. https://doi.org/10.14218/jcth.2020.00140.
Mani I, Alexopoulou A. Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic. Ann Gastroenterol 2021;34:625-633. https://doi.org/10.20524/aog.2021.0628.
Łykowska-Szuber L, Wołodźko K, Rychter AM, Szymczak-Tomczak A, Krela-Kaźmierczak I, Dobrowolska A. Liver injury in patients with coronavirus disease 2019 (COVID-19)-A narrative review. J Clin Med 2021;10. https://doi.org/10.3390/jcm10215048.
Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19. World J Clin Cases 2022;10:2063-2071. https://doi.org/10.12998/wjcc.v10.i7.2063.
Kariyawasam JC, Jayarajah U, Abeysuriya V, Riza R, Seneviratne SL. Involvement of the liver in COVID-19: A systematic review. Am J Trop Med Hyg 2022;106:1026-1041. https://doi.org/10.4269/ajtmh.21-1240.
Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol 2020;73:1231-1240. https://doi.org/10.1016/j.jhep.2020.06.006.
Dawood RM, Salum GM, El-Meguid MA. The impact of COVID-19 on liver injury. Am J Med Sci 2022;363:94-103. https://doi.org/10.1016/j.amjms.2021.11.001.
de Sousa-Moreira JL, Barbosa SMB, Gonçalves Júnior J. Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review. Clin Res Hepatol Gastroenterol 2021;45:101752. https://doi.org/10.1016/j.clinre.2021.101752.
Díaz-Castrillón FJ, Toro-Montoya AI. SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia. Med Lab 2020;24:183-205. https://doi.org/10.36384/01232576.268.
Anirvan P, Narain S, Hajizadeh N, Aloor FZ, Singh SP, Satapathy SK. Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots. Eur J Gastroenterol Hepatol 2021;33:e42-e49. https://doi.org/10.1097/meg.0000000000002034.
Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-1998. https://doi.org/10.1111/liv.14984.
Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol 2020;73:807-816. https://doi.org/10.1016/j.jhep.2020.05.002.
Liu C, Yang J, Wang W, Zheng P, Tang Y. Liver injury could be associated with severe disease in COVID-19 patients: a meta-analysis. Eur J Gastroenterol Hepatol 2022;34:237-238. https://doi.org/10.1097/meg.0000000000001953.
Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, et al. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology 2020;72:389-398. https://doi.org/10.1002/hep.31301.
Bansal A, Prasad JB. Liver profile in COVID-19: a meta-analysis. Z Gesundh Wiss 2022;30:253-258. https://doi.org/10.1007/s10389-020-01309-9.
Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021;10:301-311. https://doi.org/10.5501/wjv.v10.i6.301.
Kariyawasam JC, Jayarajah U, Riza R, Abeysuriya V, Seneviratne SL. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg 2021;115:1362-1388. https://doi.org/10.1093/trstmh/trab042.
Choudhary NS, Dhampalwar S, Saraf N, Soin AS. Outcomes of COVID-19 in patients with cirrhosis or liver transplantation. J Clin Exp Hepatol 2021;11:713-719. https://doi.org/10.1016/j.jceh.2021.05.003.
Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. World J Hepatol 2021;13:1143-1153. https://doi.org/10.4254/wjh.v13.i9.1143.
Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, et al. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol 2020;5:776-787. https://doi.org/10.1016/s2468-1253(20)30190-4.
Bhurwal A, Minacapelli CD, Orosz E, Gupta K, Tait C, Dalal I, et al. COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations. World J Gastroenterol 2021;27:7969-7981. https://doi.org/10.3748/wjg.v27.i46.7969.
Gabrielli M, Franza L, Esperide A, Gasparrini I, Gasbarrini A, Franceschi F, et al. Liver injury in patients hospitalized for covid-19: Possible role of therapy. Vaccines (Basel) 2022;10:192. https://doi.org/10.3390/vaccines10020192.
Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, et al. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol 2020;26:7693-7706. https://doi.org/10.3748/wjg.v26.i48.7693.
Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hepatol Int 2020;14:612-620. https://doi.org/10.1007/s12072-020-10078-2.
Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: A multicenter research network study. Gastroenterology 2020;159:768-771.e763. https://doi.org/10.1053/j.gastro.2020.04.064.
Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol 2020;73:1063-1071. https://doi.org/10.1016/j.jhep.2020.06.001.
Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol 2021;74:567-577. https://doi.org/10.1016/j.jhep.2020.09.024.
Boettler T, Marjot T, Newsome PN, Mondelli MU, Maticic M, Cordero E, et al. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. JHEP Rep 2020;2:100169. https://doi.org/10.1016/j.jhepr.2020.100169.
Anirvan P, Singh SP, Giammarino A, Satapathy SK. Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence. World J Hepatol 2021;13:916-925. https://doi.org/10.4254/wjh.v13.i8.916.
Zheng KI, Gao F, Wang XB, Sun QF, Pan KH, Wang TY, et al. Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism 2020;108:154244. https://doi.org/10.1016/j.metabol.2020.154244.
Holly JMP, Biernacka K, Maskell N, Perks CM. Obesity, diabetes and COVID-19: An infectious disease spreading from the east collides with the consequences of an unhealthy western lifestyle. Front Endocrinol 2020;11:582870. https://doi.org/10.3389/fendo.2020.582870.
Hu X, Sun L, Guo Z, Wu C, Yu X, Li J. Management of COVID-19 patients with chronic liver diseases and liver transplants. Ann Hepatol 2022;27:100653. https://doi.org/10.1016/j.aohep.2021.100653.
Gaspar R, Castelo-Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021;13:1367-1377. https://doi.org/10.4254/wjh.v13.i10.1367.
Ekpanyapong S, Bunchorntavakul C, Reddy KR. COVID-19 and the liver: lessons learnt from the EAST and the WEST, a year later. J Viral Hepat 2022;29:4-20. https://doi.org/10.1111/jvh.13590.
Du M, Yang S, Liu M, Liu J. COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms. Clin Res Hepatol Gastroenterol 2022;46:101793. https://doi.org/10.1016/j.clinre.2021.101793.
Harapan H, Fajar JK, Supriono S, Soegiarto G, Wulandari L, Seratin F, et al. The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta-analysis. Rev Med Virol 2021:e2304. https://doi.org/10.1002/rmv.2304.
Chan SL, Kudo M. Impacts of COVID-19 on liver cancers: During and after the pandemic. Liver Cancer 2020;9:491-502. https://doi.org/10.1159/000510765.
Alfishawy M, Nso N, Nassar M, Ariyaratnam J, Bhuiyan S, Siddiqui RS, et al. Liver transplantation during global COVID-19 pandemic. World J Clin Cases 2021;9:6608-6623. https://doi.org/10.12998/wjcc.v9.i23.6608.
Nickerson AM, Sobotka LA, Kelly SG. PRO: liver transplantation in the times of COVID-19: "To transplant or not to transplant". Clin Liver Dis (Hoboken) 2021;18:230-232. https://doi.org/10.1002/cld.1131.
Kulkarni AV, Tevethia HV, Premkumar M, Arab JP, Candia R, Kumar K, et al. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine 2021;38:101025. https://doi.org/10.1016/j.eclinm.2021.101025.
Webb GJ, Marjot T, Cook JA, Aloman C, Armstrong MJ, Brenner EJ, et al. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol Hepatol 2020;5:1008-1016. https://doi.org/10.1016/s2468-1253(20)30271-5.
Becchetti C, Gschwend SG, Dufour J-F, Banz V. COVID-19 in liver transplant recipients: A systematic review. J Clin Med 2021;10:4015. https://doi.org/10.3390/jcm10174015.
Al-Ali D, Elshafeey A, Mushannen M, Kawas H, Shafiq A, Mhaimeed N, et al. Cardiovascular and haematological events post COVID-19 vaccination: A systematic review. J Cell Mol Med 2022;26:636-653. https://doi.org/10.1111/jcmm.17137.
Global Hepatology Society Statement. Vaccination for SARS-CoV-2 in patients with liver disease. 2021. Acceso 11 de mayo de 2022. Disponible en https://www.aasld.org/sites/default/files/2021-05/Joint%20Society%20Statement%20-%20COVID-19%20Vaccination%20May%202021.pdf?fbclid=IwAR3TTUuwTpmHVernEZj8oBDRja0Le7qbpPmIt4JUQi1pwguR8Un3JYCj0wk.
Salinas MA, Arias YR, Plazas-Sierra DC. Lineamiento técnico para la Red de Donación y Trasplantes relacionado con el coronavirus SARS-CoV-2, responsable de ocasionar la enfermedad infecciosa por coronavirus (COVID-19). Bogotá D.C.: Instituto Nacional de Salud (INS); 2022. Acceso 19 de mayo de 2022.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
La política de reconocimiento de autoría de Hepatología se basa en los criterios indicados por el ICMJE para conferir crédito de un trabajo a una persona, a la vez que se le atribuye responsabilidad por la publicación del mismo.